Back to all bills
HR 1864119th CongressIntroduced
Risky Research Review Act
Introduced: Oct 28, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Risky Research Review Act creates the Life Sciences Research Security Board to review and approve federal funding for high‑risk life‑sciences research, establishes detailed procedures for agencies to report and certify such research, and imposes oversight, reporting, and enforcement mechanisms.
Key Points
- 1Establishment of an independent Life Sciences Research Security Board with a nine‑member composition.
- 2Board’s authority to review and approve federal funding for high‑risk or dual‑use research involving high‑consequence pathogens.
- 3Mandatory reporting and certification requirements for agencies and research entities.
- 4Procedures for handling changes in research status, subcontracts, and enforcement of compliance.
- 5Annual reporting, GAO audits, and $30 million annual appropriations for 2026‑2035.
Impact Areas
Federal agencies (NIH, DoD, CDC, etc.) funding life‑sciences research.Researchers and institutions conducting high‑risk or dual‑use studies.Funding recipients and contractors in the life‑sciences sector.Congressional committees overseeing national security and public health.
Generated by openai/gpt-oss-20b:free on Nov 20, 2025